- Home
- IMCR vs STAA Comparison
IMCR vs STAA Comparison
Compare IMCR & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- STAA
- Stock Information
- Founded
- IMCR 2008
- STAA 1982
- Country
- IMCR United Kingdom
- STAA United States
- Employees
- IMCR N/A
- STAA N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- STAA Ophthalmic Goods
- Sector
- IMCR Health Care
- STAA Health Care
- Exchange
- IMCR Nasdaq
- STAA Nasdaq
- Market Cap
- IMCR 1.7B
- STAA 2.0B
- IPO Year
- IMCR 2021
- STAA N/A
- Fundamental
- Price
- IMCR $32.93
- STAA $30.20
- Analyst Decision
- IMCR Buy
- STAA Buy
- Analyst Count
- IMCR 14
- STAA 7
- Target Price
- IMCR $74.75
- STAA $45.00
- AVG Volume (30 Days)
- IMCR 267.8K
- STAA 605.4K
- Earning Date
- IMCR 11-05-2024
- STAA 10-30-2024
- Dividend Yield
- IMCR N/A
- STAA N/A
- EPS Growth
- IMCR N/A
- STAA N/A
- EPS
- IMCR N/A
- STAA 0.33
- Revenue
- IMCR $280,914,000.00
- STAA $332,942,000.00
- Revenue This Year
- IMCR $25.60
- STAA $8.76
- Revenue Next Year
- IMCR $10.63
- STAA $14.28
- P/E Ratio
- IMCR N/A
- STAA $91.84
- Revenue Growth
- IMCR 27.95
- STAA 8.83
- 52 Week Low
- IMCR $29.72
- STAA $26.66
- 52 Week High
- IMCR $76.98
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- IMCR 52.76
- STAA 41.25
- Support Level
- IMCR $31.10
- STAA $29.91
- Resistance Level
- IMCR $35.47
- STAA $31.41
- Average True Range (ATR)
- IMCR 1.49
- STAA 1.07
- MACD
- IMCR 0.17
- STAA -0.08
- Stochastic Oscillator
- IMCR 51.98
- STAA 15.56
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.